Specificity of regulatory T cells that modulate vascular inflammation

References

• Burns, G. C., and M. P. Glode. 2004. Kawasaki syndrome. Lancet 364: 533–544
   PubMed Web of Science ®Google Scholar
• Franco, A., C. Shimizu, A. H. Tremoulet, and J. C. Burns. 2010. Memory T cells and characterization of peripheral T cell clones in acute Kawasaki disease. Autoimmunity 43: 317–324
   PubMed Web of Science ®Google Scholar
• Maddur, M. S., S. Othy, P. Hegde, et al. 2010. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J. Clin. Immunol. 1: S4–S8
   Google Scholar
• Burns, J. C., Y. Song, M. Bujold, et al. 2013. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clin. Exp. Immunol. 174: 337--344
   PubMedGoogle Scholar
• Campos Ramos, G., S. Dalbo, D. Pereira Leite, et al. 2012. The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing. Autoimmunity 45: 233–244
   PubMedGoogle Scholar
• Trinath, J., P. Hegde, M. Sharma, et al. 2013. Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood. 122: 1419--1427
   Google Scholar
• Roncarolo, M. G., and M. Battaglia. 2007. Regulatory T cell immunotherapy for tolerance to self antigens and to alloantigens in humans. Nat. Rev. 7: 585–598
   Google Scholar
• Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7–13
   PubMed Web of Science ®Google Scholar
• von Boehmer, H., and F. Melchers. 2010. Checkpoints in lymphocytes development and autoimmune disease. Nat. Immunol. 11: 14–20
   PubMed Web of Science ®Google Scholar
• Kassiotis, G., and A. O'Garra. 2008. Immunology. Immunity benefits from a little suppression. Science 320: 1168–1169
   PubMedGoogle Scholar
• O'Garra, A., P. L. Vieira, P. Vieira, and A. E. Goldfeld. 2004. IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J. Clin. Invest. 114: 1372–1378
   PubMed Web of Science ®Google Scholar
• Feuerer, M., J. A. Hill, D. Mathis, and C. Benoit. 2010. Foxp3+ regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 10: 698–695
   Google Scholar
• Jordan, M. S., A. Boesteanu, A. J. Reed, et al. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301–306
   PubMed Web of Science ®Google Scholar
• Miyara, M., Y. Yoshioka, A. Kito, et al. 2009. Functional delineation and differentiation dinamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899–911
   PubMed Web of Science ®Google Scholar
• Chen, W. J., W. Jin, N. Hardegen, et al. 2003. Conversion of peripheral CD4+CD25-naive T Cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875–1886
   PubMed Web of Science ®Google Scholar
• Kretschmer, K., I. Apostolou, D. Hawiger, et al. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6: 1–9
   PubMedGoogle Scholar
• Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3: 756–763
   PubMed Web of Science ®Google Scholar
• Apostolou, I., and H. von Boeme. 2004. In vivo instruction od suppressor committment in naive T cells. J. Exp. Med. 199: 1401–1408
   PubMed Web of Science ®Google Scholar
• Rivino, L., R. L. Gruarin, H. B. Steinfelder, et al. 2010. CCR6 is expressed on IL-10 producing, autoreactive memory T cell population with context-dependent regulatory function. J. Exp. Med. 207: 565–577
   PubMedGoogle Scholar
• Ohkura, N., Y. Kitagawa, and S. Sakaguchi. 2013. Development and maintenance of regulatory T cells. Immunity 38: 414–423
   PubMed Web of Science ®Google Scholar
• Chaudry, A., and A. Y. Rudensky. 2013. Control of inflammation by integration of environmental cues by regulatory T cells. J. Clin. Invest. 123: 939–944
   PubMedGoogle Scholar
• Sakaguchi, S., D. A. Vignali, A. Y. Rudensky, et al. 2013. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13: 461–467
   PubMed Web of Science ®Google Scholar
• Povoleri, G. A., C. Scottà, E. A. Nova-Lamperti, et al. 2013. Thymic versus induced regulatory T cells – who regulates the regulators? Front. Immunol. 4: 1--20
   Google Scholar
• De Groot, A. S., L. Moise, J. A. McMurry, et al. 2008. Activation of natural regulatory T cells by IG Fc-derived peptide “Tregitopes”. Blood 112: 3303–3311
   PubMed Web of Science ®Google Scholar
• Franco, A., M. Paroli, U. Testa, et al. 1992. Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes. J. Exp. Med. 175: 1195–1205
   PubMedGoogle Scholar
• Zlotnik, A., and O. Yoshie. 2012. The chemokine superfamily revisited. Immunity 36: 705–716
   PubMed Web of Science ®Google Scholar
• Maddur, M. S., S. V. Kaveri, and J. Bayry. 2011. Comparison of different IVIG preparations on IL-17 production by human Th17 cells. Autoimmun. Rev. 12: 809–810
   Google Scholar
• Ephrem, A., S. Chamat, C. Miquel, et al. 2008. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalitis. Blood 111: 715–722
   PubMed Web of Science ®Google Scholar
• Reboldi, A., C. Coisne, D. Baumjohann, et al. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514–523
   PubMed Web of Science ®Google Scholar
• Zielinski, C. E., F. Mele, D. Aschenbrenner, et al. 2012. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 484: 514–518
   PubMed Web of Science ®Google Scholar
• Ward, E. S. 2004. Acquiring maternal immunoglobulin; different receptors, similar functions. Immunity 20: 507–508
   PubMedGoogle Scholar
• He, W., M. S. Ladinsky, K. E. Huey-Tubman, et al. 2008. FcRn-mediated antibody transport across epithelial cells revealed by electron tomography. Nature 455: 542–546
   PubMedGoogle Scholar
• Rizzi, M., M. Gerloni, A. S. Srivastava, et al. 2005. In utero DNA immunisation. Immunity over tolerance in fetal life. Vaccine 23: 4273–4283
   PubMedGoogle Scholar
• Bayry, J., V. S. Negi, and S. V. Kaveri. 2011. Intravenous immunoglobulin therapy in rheumatic diseases. Nat. Rev. Rheumatol. 7: 349–359
   PubMed Web of Science ®Google Scholar